» Articles » PMID: 33187554

PD-L1 Correlates with Chemokines and Cytokines in Gingival Crevicular Fluid from Healthy and Diseased Sites in Subjects with Periodontitis

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2020 Nov 14
PMID 33187554
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: PD-L1 is an immune checkpoint molecule that regulates immune and inflammatory responses. While cells of periodontal tissues express PD-L1, its presence in GCF is not known. The purpose of this study was to measure the PD-L1 values in GCF and correlate values with the presence of chemokine and cytokine values from periodontally diseased subjects and periodontally healthy subjects.

Results: PD-L1 values (pg/30 s), determined in triplicate using a fluorescent microparticle-based immunoassay ranged from 0.04-31.65 pg/30 s. PD-L1 correlated with 15 out of 22 chemokine and cytokine responses. In 85 healthy sites in 31 subjects, PD-L1 values were negatively correlated with IL6, CXCL8, IL10, and CCL3 values. In 53 diseased sites in 20 subjects, PD-L1 values were positively correlated with CCL11, CSF2, IFNG, IL1A, IL1B, IL2, IL7, IL15, and CCL5 values and negatively correlated with IL12A and IL5 values. Gene ontology (GO) annotations identified roles of PD-L1 in Th1 and Th2 activation and T-cell exhaustion signaling canonical pathways. PD-L1 values were correlated with the expression of chemokines and cytokines, which likely regulates immune cell trafficking and protects the periodontium from uncontrolled immune responses to pathogens and inflammation-induced tissue damage.

Citing Articles

Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy.

Wang L, Zhou X, Yan H, Miao Y, Wang B, Gu Y Front Immunol. 2024; 15:1460308.

PMID: 39328412 PMC: 11424447. DOI: 10.3389/fimmu.2024.1460308.


The role of programmed death receptor (PD-)1/PD-ligand (L)1 in periodontitis and cancer.

Groeger S, Meyle J Periodontol 2000. 2024; 96(1):150-169.

PMID: 38351432 PMC: 11579837. DOI: 10.1111/prd.12548.


Effects of periodontitis on cancer outcomes in the era of immunotherapy.

Pai S, Matheus H, Guastaldi F Lancet Healthy Longev. 2023; 4(4):e166-e175.

PMID: 37003275 PMC: 10148268. DOI: 10.1016/S2666-7568(23)00021-1.


PD-L1, a Potential Immunomodulator Linking Immunology and Orthodontically Induced Inflammatory Root Resorption (OIIRR): Friend or Foe?.

Yong J, Groger S, von Bremen J, Meyle J, Ruf S Int J Mol Sci. 2022; 23(19).

PMID: 36232704 PMC: 9570182. DOI: 10.3390/ijms231911405.


Immunorthodontics: PD-L1, a Novel Immunomodulator in Cementoblasts, Is Regulated by HIF-1α under Hypoxia.

Yong J, Groger S, von Bremen J, Meyle J, Ruf S Cells. 2022; 11(15).

PMID: 35954195 PMC: 9367578. DOI: 10.3390/cells11152350.


References
1.
Berglundh T, Liljenberg B, Lindhe J . Some cytokine profiles of T-helper cells in lesions of advanced periodontitis. J Clin Periodontol. 2002; 29(8):705-9. DOI: 10.1034/j.1600-051x.2002.290807.x. View

2.
Figueira E, de Rezende M, Torres S, Garlet G, Lara V, Santos C . Inhibitory signals mediated by programmed death-1 are involved with T-cell function in chronic periodontitis. J Periodontol. 2009; 80(11):1833-44. DOI: 10.1902/jop.2009.090057. View

3.
Papapanou P, Sanz M, Buduneli N, Dietrich T, Feres M, Fine D . Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018; 89 Suppl 1:S173-S182. DOI: 10.1002/JPER.17-0721. View

4.
Chen J, Jiang C, Jin L, Zhang X . Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Ann Oncol. 2015; 27(3):409-16. DOI: 10.1093/annonc/mdv615. View

5.
Seymour G, Gemmell E, Reinhardt R, Eastcott J, Taubman M . Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res. 1993; 28(6 Pt 2):478-86. DOI: 10.1111/j.1600-0765.1993.tb02108.x. View